These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 32412070)
1. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry. Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070 [TBL] [Abstract][Full Text] [Related]
2. Utility of the SEER-Medicare data to identify chemotherapy use. Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169 [TBL] [Abstract][Full Text] [Related]
3. Comparison of SEER Treatment Data With Medicare Claims. Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data. Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197 [TBL] [Abstract][Full Text] [Related]
5. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665 [TBL] [Abstract][Full Text] [Related]
6. Construct validity of medicare chemotherapy claims: the case of 5FU. Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793 [TBL] [Abstract][Full Text] [Related]
7. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392 [TBL] [Abstract][Full Text] [Related]
8. Identifying specific chemotherapeutic agents in Medicare data: a validation study. Lund JL; Stürmer T; Harlan LC; Sanoff HK; Sandler RS; Brookhart MA; Warren JL Med Care; 2013 May; 51(5):e27-34. PubMed ID: 22080337 [TBL] [Abstract][Full Text] [Related]
9. Mammography use, breast cancer stage at diagnosis, and survival among older women. McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009 [TBL] [Abstract][Full Text] [Related]
10. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. Healy MA; Morris AM; Abrahamse P; Ward KC; Kato I; Veenstra CM BMC Cancer; 2018 Apr; 18(1):481. PubMed ID: 29703172 [TBL] [Abstract][Full Text] [Related]
11. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973 [TBL] [Abstract][Full Text] [Related]
12. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment. Lin CC; Virgo KS Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Reliability and Correlations of Quality Measures in Cancer Care. Keating NL; Cleveland JLF; Wright AA; Brooks GA; Meneades L; Riedel L; Zubizarreta JR; Landrum MB JAMA Netw Open; 2021 Mar; 4(3):e212474. PubMed ID: 33749769 [TBL] [Abstract][Full Text] [Related]
15. Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data. Gore JL; Wright P; Shih V; Chang NN; Noshad S; Rey GG; Wang S; Narayanan S JCO Clin Cancer Inform; 2024 Sep; 8():e2400073. PubMed ID: 39298694 [TBL] [Abstract][Full Text] [Related]
16. Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study. Schroeder MC; Chapman CG; Nattinger MC; Halfdanarson TR; Abu-Hejleh T; Tien YY; Brooks JM BMC Health Serv Res; 2016 Jul; 16():274. PubMed ID: 27430623 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Gold HT; Do HT Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533 [TBL] [Abstract][Full Text] [Related]
18. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355 [TBL] [Abstract][Full Text] [Related]
19. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries. Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536 [TBL] [Abstract][Full Text] [Related]
20. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data. Huepenbecker SP; Zhao H; Sun CC; Fu S; He W; Giordano SH; Meyer LA JCO Clin Cancer Inform; 2022 Mar; 6():e2100187. PubMed ID: 35297648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]